These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 26509840)

  • 1. Long Withdrawal of Methylphenidate Induces a Differential Response of the Dopaminergic System and Increases Sensitivity to Cocaine in the Prefrontal Cortex of Spontaneously Hypertensive Rats.
    dos Santos Pereira M; Sathler MF; Valli Tda R; Marques RS; Ventura AL; Peccinalli NR; Fraga MC; Manhães AC; Kubrusly R
    PLoS One; 2015; 10(10):e0141249. PubMed ID: 26509840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential behavioral and neurochemical effects of cocaine after early exposure to methylphenidate in an animal model of attention deficit hyperactivity disorder.
    Augustyniak PN; Kourrich S; Rezazadeh SM; Stewart J; Arvanitogiannis A
    Behav Brain Res; 2006 Feb; 167(2):379-82. PubMed ID: 16246436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences between electrically-, ritalin- and D-amphetamine-stimulated release of [3H]dopamine from brain slices suggest impaired vesicular storage of dopamine in an animal model of Attention-Deficit Hyperactivity Disorder.
    Russell V; de Villiers A; Sagvolden T; Lamm M; Taljaard J
    Behav Brain Res; 1998 Jul; 94(1):163-71. PubMed ID: 9708847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of environmental enrichment on methylphenidate-induced locomotion and dopamine transporter dynamics.
    Wooters TE; Bardo MT; Dwoskin LP; Midde NM; Gomez AM; Mactutus CF; Booze RM; Zhu J
    Behav Brain Res; 2011 May; 219(1):98-107. PubMed ID: 21219939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type.
    Roessner V; Sagvolden T; Dasbanerjee T; Middleton FA; Faraone SV; Walaas SI; Becker A; Rothenberger A; Bock N
    Neuroscience; 2010 Jun; 167(4):1183-91. PubMed ID: 20211696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adolescence methylphenidate treatment in a rodent model of attention deficit/hyperactivity disorder: dopamine transporter function and cellular distribution in adulthood.
    Somkuwar SS; Darna M; Kantak KM; Dwoskin LP
    Biochem Pharmacol; 2013 Jul; 86(2):309-16. PubMed ID: 23623751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adolescent atomoxetine treatment in a rodent model of ADHD: effects on cocaine self-administration and dopamine transporters in frontostriatal regions.
    Somkuwar SS; Jordan CJ; Kantak KM; Dwoskin LP
    Neuropsychopharmacology; 2013 Dec; 38(13):2588-97. PubMed ID: 23822950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylphenidate sensitization is prevented by prefrontal cortex lesion.
    Lee MJ; Swann AC; Dafny N
    Brain Res Bull; 2008 May; 76(1-2):131-40. PubMed ID: 18395622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylphenidate does not increase ethanol consumption in a rat model for attention-deficit hyperactivity disorder-the spontaneously hypertensive rat.
    Soeters HS; Howells FM; Russell VA
    Metab Brain Dis; 2008 Sep; 23(3):303-14. PubMed ID: 18665438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of chronic methylphenidate administration on presynaptic dopaminergic parameters in a rat model for ADHD.
    Simchon Y; Weizman A; Rehavi M
    Eur Neuropsychopharmacol; 2010 Oct; 20(10):714-20. PubMed ID: 20493667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theobromine improves hyperactivity, inattention, and working memory
    Matsuzaki K; Sugimoto N; Hossain S; Islam R; Sumiyoshi E; Hashimoto M; Kishi H; Shido O
    Food Funct; 2024 May; 15(10):5579-5595. PubMed ID: 38713055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cocaine-seeking behavior in a genetic model of attention-deficit/hyperactivity disorder following adolescent methylphenidate or atomoxetine treatments.
    Jordan CJ; Harvey RC; Baskin BB; Dwoskin LP; Kantak KM
    Drug Alcohol Depend; 2014 Jul; 140():25-32. PubMed ID: 24811203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylphenidate treatment in adolescent rats with an attention deficit/hyperactivity disorder phenotype: cocaine addiction vulnerability and dopamine transporter function.
    Harvey RC; Sen S; Deaciuc A; Dwoskin LP; Kantak KM
    Neuropsychopharmacology; 2011 Mar; 36(4):837-47. PubMed ID: 21150910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adolescent D-amphetamine treatment in a rodent model of ADHD: Pro-cognitive effects in adolescence without an impact on cocaine cue reactivity in adulthood.
    Jordan CJ; Taylor DM; Dwoskin LP; Kantak KM
    Behav Brain Res; 2016 Jan; 297():165-79. PubMed ID: 26467602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of α2-adrenergic receptors in prelimbic cortex: impact on cocaine self-administration in adult spontaneously hypertensive rats following adolescent atomoxetine treatment.
    Baskin BM; Nic Dhonnchadha BÁ; Dwoskin LP; Kantak KM
    Psychopharmacology (Berl); 2017 Oct; 234(19):2897-2909. PubMed ID: 28730282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder.
    Somkuwar SS; Kantak KM; Dwoskin LP
    J Neurosci Methods; 2015 Aug; 252():55-63. PubMed ID: 25680322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cocaine on striatal dopamine clearance in a rat model of developmental stress and attention-deficit/hyperactivity disorder.
    Womersley JS; Kellaway LA; Stein DJ; Gerhardt GA; Russell VA
    Stress; 2016; 19(1):78-82. PubMed ID: 26394534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylphenidate alters basal ganglia neurotensin systems through dopaminergic mechanisms: a comparison with cocaine treatment.
    Alburges ME; Hoonakker AJ; Horner KA; Fleckenstein AE; Hanson GR
    J Neurochem; 2011 May; 117(3):470-8. PubMed ID: 21323925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventative treatment in an animal model of ADHD: Behavioral and biochemical effects of methylphenidate and its interactions with ovarian hormones in female rats.
    Lukkes JL; Freund N; Thompson BS; Meda S; Andersen SL
    Eur Neuropsychopharmacol; 2016 Sep; 26(9):1496-1506. PubMed ID: 27397110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylphenidate affects striatal dopamine differently in an animal model for attention-deficit/hyperactivity disorder--the spontaneously hypertensive rat.
    Russell VA; de Villiers AS; Sagvolden T; Lamm MC; Taljaard JJ
    Brain Res Bull; 2000 Sep; 53(2):187-92. PubMed ID: 11044595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.